RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $329
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix maintains an Outperform rating on HCA Healthcare (NYSE:HCA) and raises the price target from $322 to $329.
April 29, 2024 | 2:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix maintains an Outperform rating on HCA Healthcare and raises the price target from $322 to $329.
The increase in the price target by RBC Capital suggests a positive outlook on HCA Healthcare's stock, likely due to strong performance or favorable market conditions. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100